US Senator Sanders Investigates $375,000 Price On Old Drug Previously Available For Free

Mining Awareness +

The drug was invented in Scotland in the 1970s, and has been given away for free by Jacobus pharmaceuticals for 20 years. One need only look at this case to see why medical price caps are essential. Neither individuals nor insurance companies nor the US taxpayer can afford US medical charges. The Canadian system works only because of caps on charges, and not just drug charges. US doctors are gouging too.

The $375,000 would even take a big chunk out of the Catalyst CEO, Patrick J McEnany,’s $900.000 salary. US Senator Sanders explains: “Recently, Catalyst licensed the rights to the drug and received exclusive rights to market Firdapse for seven years under the FDA’s orphan drug designation. In December 2018, Catalyst announced to investors it would set the list price for Firdapse at $375,000 per year

Catalyst was sued by investors in 2013 for failure to disclose the…

View original post 806 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.